Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
28.38
-0.10 (-0.35%)
At close: Feb 13, 2026

SHA:688443 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
10,4069,20014,649---
Market Cap Growth
12.75%-37.20%----
Enterprise Value
9,1387,40512,246---
Last Close Price
28.3825.0939.95---
PS Ratio
46.22305.7012091.50---
PB Ratio
5.824.335.26---
P/TBV Ratio
5.964.425.35---
EV/Sales Ratio
40.58246.0410108.38---
Debt / Equity Ratio
0.590.390.2326.891.83-0.93
Net Debt / Equity Ratio
-0.71-0.76-0.8217.030.42-0.78
Net Debt / EBITDA Ratio
2.232.053.05-0.87-0.48-0.92
Net Debt / FCF Ratio
2.642.604.86-1.53-0.37-1.49
Asset Turnover
0.070.010.0000.050.00
Inventory Turnover
0.240.11-0.040.800.05
Quick Ratio
7.0714.1221.332.275.150.13
Current Ratio
7.5915.0522.153.166.150.22
Return on Equity (ROE)
-28.18%-32.47%-56.97%-337.99%--
Return on Assets (ROA)
-12.42%-15.62%-21.82%-38.85%-25.14%-45.69%
Return on Capital Employed (ROCE)
-23.20%-28.30%-23.00%-73.10%-32.90%-1923.60%
Earnings Yield
-5.61%-8.67%-5.47%---
FCF Yield
-4.61%-6.75%-3.20%---
Buyback Yield / Dilution
-0.03%-14.63%-16.79%0.32%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.